Published on the 27 February 2018
Strok@lliance – Newsletter #1
Focus on an innovative model of thromboembolic stroke reproducing the clinical situation
Recombinant tissue-type plasminogen activator (rt-PA) is the only approved drug treatment at the acute p…
Technical notes
